Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

42000001

Sigma-Aldrich

PRONOVA® UP LVG

low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 %

Sinónimos:

Ultra-Pure Low Viscosity Gel

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

UNSPSC Code:
12352201
NACRES:
NA.25

Quality Level

100

form

powder

mol wt

Mw 75-200 kDa (approximate)

composition

guluronate monomer units, ≥60%
G/M ratio, ≥1.5

impurities

≤100 CFU/g Total viable count
≤100 EU/g Endotoxins

pH

5.5-8.5 (20 °C, 1% in water)

viscosity

20-200 mPa.s, 1 %(20 °C) (
low)

General description

PRONOVA UP LVG is a low viscosity (20-200 mPas) sodium alginate where minimum 60% of the monomer units are guluronate.

Application

Examples of Pronova UltraPure Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

Legal Information

Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.

Disclaimer

NOT FOR USE IN HUMANS

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico